Logotipo del repositorio
Logotipo del repositorio
 

Comparación del riesgo de nefropatía inducida por contraste en pacientes con coronariografía en un tiempo versus dos tiempos en un hospital de IV nivel de Barranquilla entre junio 2021- junio 2023

Vista sencilla de ítem
datacite.rightshttp://purl.org/coar/access_right/c_16ec
dc.contributor.advisorCabarcas Barbosa, Omar
dc.contributor.advisorCadena Bonfanti, Andres Angélo
dc.contributor.authorHenao Navarro, Luis Fernando
dc.date.accessioned2024-01-16T16:20:15Z
dc.date.available2024-01-16T16:20:15Z
dc.date.issued2023
dc.description.abstractLa nefropatía inducida por medio de contraste (NIC) es una complicación aguda que afecta los riñones después de la administración de medios de contraste utilizados en procedimientos de diagnóstico por imágenes. se define a un paciente con NIC si experimenta un aumento de al menos 0,5 mg por decilitro (equivalente a 44 micromoles por litro) o un incremento del 25 % en su nivel de creatinina plasmática en un período de 2 a 5 días tras la exposición al medio de contraste;se manifiesta como una disfunción renal, caracterizada por un rápido aumento de los niveles de creatinina y nitrógeno ureico en sangre, indicando una disminución en la tasa de filtración glomerular. Objetivo: comparar el riesgo de nefropatía inducida por contraste en pacientes con coronariografía en un tiempo versus dos tiempos en una institución de cuarto nivel de la costa caribe colombiana durante el periodo de junio 2021 a junio 2023. Metodología: En este trabajo se incluyó de manera retrospectiva un total de 377 pacientes que recibieron al menos un cateterismo de los cuales recibieron único cateterismo 312 pacientes, dos cateterismos a 63 pacientes y 3 cateterismos en 2 pacientes para un total de 433 cateterismos evaluados. Resultados: El OR para desarrollar Nefropatía inducida por medio de contraste en el grupo que fue sometido a dos o más cateterismos fue 1,34 veces más con respecto al grupo en el que se realizó un cateterismo con un intervalo de confianza estadísticamente no significativo (0,67 a 2,68). En la valoración de La prevalencia de nefropatía inducida por medio de contraste en el total de cateterismos evaluados fue del 8,11%, siendo del 7,76% para el primer grupo de primer cateterismo y del 10,17% para el grupo de dos o más cateterismos. Conclusión: La ausencia de Resultados concluyentes pudo deberse al tamaño de muestra pequeño para el grupo que recibió dos o más cateterismos, sin embargo, es concordante con lo descrito mundialmente en la literatura debido a que los estudios reportan una baja prevalencia en exposiciones únicas como repetidas a medios de contraste por cateterismo cardiaco.spa
dc.description.abstractContrast-induced nephropathy (CIN) is an acute complication affecting the kidneys after the administration of contrast media used in diagnostic imaging procedures. A patient is defined as having CIN if they experience an increase of at least 0.5 mg per deciliter (equivalent to 44 micromoles per liter) or a 25% increase in their plasma creatinine level within 2 to 5 days after surgery. exposure to contrast medium; manifests as renal dysfunction, characterized by a rapid increase in blood urea nitrogen and creatinine levels, indicating a decrease in the glomerular filtration rate. Objective: to compare the risk of contrast-induced nephropathy in patients with one-stage versus two-stage coronary angiography in a fourth-level institution on the Colombian Caribbean coast during the period from June 2021 to June 2023. Methodology: In this work, a total of 377 patients who received at least one catheterization were retrospectively included, of which 312 patients received a single catheterization, two catheterizations in 63 patients and 3 catheterizations in 2 patients for a total of 433 catheterizations evaluated. Results: The OR for developing contrast medium-induced nephropathy in the group that underwent two or more catheterizations was 1.34 times higher compared to the group in which one catheterization was performed with a statistically non-significant confidence interval (0 .67 to 2.68). In the assessment of the prevalence of contrast medium-induced nephropathy in the total catheterizations evaluated was 8.11%, being 7.76% for the first group of first catheterization and 10.17% for the group of two or more catheterizations. Conclusion: The absence of conclusive results could be due to the small sample size for the group that received two or more catheterizations, however, it is consistent with what is described worldwide in the literature because the studies report a low prevalence in single and repeated exposures. to contrast media by cardiac catheterization.eng
dc.format.mimetypepdf
dc.identifier.urihttps://hdl.handle.net/20.500.12442/13785
dc.language.isospa
dc.publisherEdiciones Universidad Simón Bolívarspa
dc.publisherFacultad de Ciencias de la Saludspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacionaleng
dc.rights.accessrightsinfo:eu-repo/semantics/restrictedAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCoronariografíaspa
dc.subjectNefropatía inducida por medio de contrastespa
dc.subjectInjuria renal agudaspa
dc.subjectAngiografía coronariaspa
dc.subjectCoronary angiographyeng
dc.subjectContrast medium-induced nephropathyeng
dc.subjectAcute kidney injuryeng
dc.subjectCoronary angiographyeng
dc.titleComparación del riesgo de nefropatía inducida por contraste en pacientes con coronariografía en un tiempo versus dos tiempos en un hospital de IV nivel de Barranquilla entre junio 2021- junio 2023spa
dc.type.driverinfo:eu-repo/semantics/other
dc.type.spaOtros
dcterms.referencesVillalón DraXC, Villalón DraXC, Moreno DraYRB, Mirabal DraGG, Carrillo DraAM, Pouymiro DraSH, et al. Nefropatía inducida por contraste en la cardiología intervencionista. Revista Cubana de Cardiología y Cirugía Cardiovascular [Internet]. 2017 Oct 27 [cited 2022 May 15];23(3):387–99. Available from: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/703spa
dcterms.referencesTrivedi H, Foley WD. Contrast-induced nephropathy after a second contrast exposure. Ren Fail [Internet]. 2010 Aug [cited 2022 May 15];32(7):796–801. Available from: https://pubmed.ncbi.nlm.nih.gov/20662692/eng
dcterms.referencesCateterismo cardíaco - Mayo Clinic [Internet]. [cited 2022 May 15]. Available from: https://www.mayoclinic.org/es-es/tests-procedures/cardiac-catheterization/about/pac-20384695eng
dcterms.referencesAguirre M, Aguirre Caicedo M, Aguirre Caicedo Carrera M, Miguel - E. Nefropatía por medios de contraste Nephropaty Due To Contrast Means CA I CE DO • M A NI Z A L E S ( C A L DA S ).eng
dcterms.referencesBouzas-Mosquera A, Vázquez-Rodríguez JM, Calviño-Santos R, Peteiro-Vázquez J, Flores-Ríos X, Marzoa-Rivas R, et al. Nefropatía inducida por contraste y fracaso renal agudo tras cateterismo cardiaco urgente: incidencia, factores de riesgo y pronóstico. Rev Esp Cardiol [Internet]. 2007 Oct 1 [cited 2022 May 15];60(10):1026–34. Available from: http://www.revespcardiol.org/es-nefropatia-inducida-por-contraste-fracaso-articulo-13111234spa
dcterms.referencesTrivedi H, Foley WD. Contrast-induced nephropathy after a second contrast exposure. Ren Fail. 2010 Aug 21;32(7):796–801.eng
dcterms.referencesLiu L, Liu J, Lei L, Wang B, Sun G, Guo Z, et al. A prediction model of contrast-associated acute kidney injury in patients with hypoalbuminemia undergoing coronary angiography. BMC Cardiovasc Disord. 2020 Dec 31;20(1):399.eng
dcterms.referencesNovak JE, Handa R. Contrast Nephropathy Associated with Percutaneous Coronary Angiography and Intervention. Cardiol Clin. 2019 Aug;37(3):287–96.eng
dcterms.referencesMcCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Epidemiology and Prognostic Implications of Contrast-Induced Nephropathy. Am J Cardiol. 2006 Sep;98(6):5–13.eng
dcterms.references2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2014 Oct 1;35(37):2541–619.eng
dcterms.referencesGómez-Menchero AE, Díaz JF, Sánchez-González C, Cardenal R, Sanghvi AB, Roa-Garrido J, et al. Comparación de angiografía coronaria rotacional de doble eje (XPERSWING) frente a técnica convencional en la práctica habitual. Rev Esp Cardiol. 2012 May;65(5):434–9.spa
dcterms.referencesKooiman J, Sijpkens YWJ, de Vries JPPM, Brulez HFH, Hamming JF, van der Molen AJ, et al. A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography. Nephrology Dialysis Transplantation. 2014 May;29(5):1029–36.eng
dcterms.referencesKaladee A, Phinyo P, Chantadansuwan T, Patumanond J, Siribumrungwong B. Clinical Scoring for Prediction of Acute Kidney Injury in Patients with Acute ST-Segment Elevation Myocardial Infarction after Emergency Primary Percutaneous Coronary Intervention. J Clin Med. 2021 Jul 30;10(15):3402.eng
dcterms.referencesOng MY, Koh JJH, Kothan S, Lai C. The Incidence and Associated Risk Factors of Contrast-Induced Nephropathy after Contrast-Enhanced Computed Tomography in the Emergency Setting: A Systematic Review. Life (Basel). 2022 Jun 1;12(6).eng
dcterms.referencesBetoko A, Matheson MB, Ostovaneh MR, Miller JM, Brinker J, Cox C, et al. Acute Kidney Injury After Repeated Exposure to Contrast Material for Coronary Angiography. Mayo Clin Proc Innov Qual Outcomes. 2021 Feb;5(1):46–54.eng
dcterms.referencesKaladee A, Phinyo P, Chantadansuwan T, Patumanond J, Siribumrungwong B. Clinical Scoring for Prediction of Acute Kidney Injury in Patients with Acute ST-Segment Elevation Myocardial Infarction after Emergency Primary Percutaneous Coronary Intervention. J Clin Med. 2021 Jul 30;10(15):3402.eng
dcterms.referencesLimbong M, Herry Y, Ardhianto P, Suhartono S. Risk score of contrast-induced nephropathy in patients after percutaneous coronary intervention. Bali Medical Journal. 2021 Apr 30;10(1):400.eng
dcterms.referencesHinson JS, al Jalbout N, Ehmann MR, Klein EY. Acute kidney injury following contrast media administration in the septic patient: A retrospective propensity-matched analysis. J Crit Care. 2019;51:111–6.eng
dcterms.referencesBrito C, Falcão L, Raimundo M, Fernandes S, Fernandes A, Silva S, et al. Contrast-induced acute kidney injury in acute ischaemic stroke patients. Neuroradiol J. 2020 Dec 7;1971400920977206.eng
dcterms.referencesHuang MK, Hsu TF, Chiu YH, Chiang SC, Kao WF, Yen DHT, et al. Risk factors for acute kidney injury in the elderly undergoing contrast-enhanced computed tomography in the emergency department. J Chin Med Assoc. 2013 May;76(5):271–6.eng
dcterms.referencesTraub SJ, Kellum JA, Tang A, Cataldo L, Kancharla A, Shapiro NI. Risk factors for radiocontrast nephropathy after emergency department contrast-enhanced computerized tomography. Acad Emerg Med. 2013 Jan;20(1):40–5.eng
dcterms.referencesFernández-Rodríguez D, Grillo-Pérez JJ, Pérez-Hernández H, Rodríguez-Esteban M, Pimienta R, Acosta-Materán C, et al. Evaluación prospectiva del desarrollo de nefropatía inducida por contraste en pacientes con síndrome coronario agudo tratados con angiografía coronaria rotacional vs. angiografía coronaria convencional: Estudio CINERAMA. Nefrología. 2018 Mar;38(2):169–78.spa
dcterms.referencesDinesch V, Dinesch M, Macarie C, Sirbu IV, Buruian M. Risk of Contrast-Induced Nephropathy after Repeated Contrast Medium Administration. Acta Med Marisiensis. 2018 Sep 1;64(3):108–10.eng
dcterms.referencesMoura ELB de, Amorim FF, Huang W, Maia M de O. Contrast-induced acute kidney injury: the importance of diagnostic criteria for establishing prevalence and prognosis in the intensive care unit. Rev Bras Ter Intensiva. 2017;29(3).eng
dcterms.referencesMoos SI, Nagan G, de Weijert RS, van Vemde DNH, Stoker J, Bipat S. Patients at risk for contrast-induced nephropathy and mid-term effects after contrast administration: a prospective cohort study. Neth J Med. 2014 Sep;72(7):363–71.eng
dcterms.referencesMaioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F. Persistent Renal Damage After Contrast-Induced Acute Kidney Injury. Circulation. 2012 Jun 26;125(25):3099–107.eng
dcterms.referencesTirado Castro MJ, Cataño Vargas LR, Prieto Alvarado FE. Factores asociados a la nefropatía inducida por contraste en pacientes hospitalizados a quienes se les realizó tomografía axial computarizada. Rev Colomb Nefrol 2018;5:118. https://doi.org/10.22265/acnef.0.0.303.spa
dcterms.referencesFerreira Morales JL. Actualidad en nefropatía por medio de contraste. Nefrología Latinoamericana 2017;14:69–78. https://doi.org/10.1016/j.nefrol.2017.03.001.spa
dcterms.referencesAguirre Caicedo M. Nefropatía por medios de contraste. Acta Medica Colombiana 2007;32:68–79.spa
dcterms.referencesThomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) Guidelines. Br J Radiol. 2003 Aug;76(908):513–8.eng
dcterms.referencesStacul F, van der Molen AJ, Reimer P, Webb JAW, Thomsen HS, Morcos SK, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011 Dec 25;21(12):2527–41eng
dcterms.referencesArias Leal ML, Ramírez Vargas X, Madrigal Zamora S. Lesión renal aguda inducida por medio de contraste. Revista Medica Sinergia. 2020 Oct 1;5(10):e586.spa
dcterms.referencesMehran R, Dangas GD, Weisbord SD. Contrast-Associated Acute Kidney Injury. New England Journal of Medicine [Internet]. 2019 May 30 [cited 2022 May 15];380(22):2146–55. Available from: https://www.nejm.org/doi/full/10.1056/NEJMra1805256eng
dcterms.referencesFerreira Morales JL. Actualidad en nefropatía por medio de contraste. Nefrología Latinoamericana. 2017 Apr;14(2):69–78.spa
dcterms.referencesChandiramani R, Cao D, Nicolas J, Mehran R. Contrast-induced acute kidney injury. Cardiovascular Intervention and Therapeutics 2020 35:3 [Internet]. 2020 Apr 6 [cited 2022 May 15];35(3):209–17. Available from: https://link.springer.com/article/10.1007/s12928-020-00660-8eng
dcterms.referencesRudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int [Internet]. 1995 [cited 2022 May 15];47(1):254–61. Available from: https://pubmed.ncbi.nlm.nih.gov/7731155/eng
dcterms.referencesCigarroa RG, Lange RA, Williams RH, Hillis D. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989 Jun;86(6):649–52.eng
dcterms.referencesMcCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute Renal Failure After Coronary Intervention. Am J Med. 1997 Nov;103(5):368–75.eng
dcterms.referencesLautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol [Internet]. 1991 [cited 2022 May 15];157(1):49–58. Available from: https://pubmed.ncbi.nlm.nih.gov/2048539eng
dcterms.referencesMarenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, de Metrio M, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med [Internet]. 2009 Feb 3 [cited 2022 May 15];150(3):170–7. Available from: https://pubmed.ncbi.nlm.nih.gov/19189906eng
dcterms.referencesKushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). Circulation [Internet]. 2009 Dec 1 [cited 2022 May 15];120(22):2271–306. Available from: https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.109.192663eng
dcterms.referencesKDIGO Clinical Practice Guideline for Acute Kidney Injury. [cited 2022 May 15]; Available from: http://www.kidney-international.orgeng
dcterms.referencesWeisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol [Internet]. 2008 Jan [cited 2022 May 15];3(1):273–80. Available from: https://pubmed.ncbi.nlm.nih.gov/17989201/eng
dcterms.referencesMueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med [Internet]. 2002 Feb 11 [cited 2022 May 15];162(3):329–36. Available from: https://pubmed.ncbi.nlm.nih.gov/11822926/eng
dcterms.referencesPannu N, Wiebe N, Tonelli M. Prophylaxis Strategies for Contrast-Induced Nephropathy. JAMA [Internet]. 2006 Jun 21 [cited 2022 May 15];295(23):2765–79. Available from: https://jamanetwork.com/journals/jama/fullarticle/203013eng
dcterms.referencesAlonso A, Lau J, Jaber BL, Weintraub A, Sarnak MJ. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. American Journal of Kidney Diseases. 2004 Jan;43(1):1–9.eng
dcterms.referencesWeisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, et al. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. New England Journal of Medicine. 2018 Feb 15;378(7):603–14.eng
dcterms.referencesKshirsagar A v., Poole C, Mottl A, Shoham D, Franceschini N, Tudor G, et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol [Internet]. 2004 Mar [cited 2022 May 15];15(3):761–9. Available from: https://pubmed.ncbi.nlm.nih.gov/14978179/eng
dcterms.referencesAcetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography. Circulation. 2011 Sep 13;124(11):1250–9.eng
dcterms.referencesWebb JG, Pate GE, Humphries KH, Buller CE, Shalansky S, al Shamari A, et al. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effect. Am Heart J. 2004 Sep;148(3):422–9.eng
dcterms.referencesBaker CSR, Wragg A, Kumar S, de Palma R, Baker LRI, Knight CJ. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol [Internet]. 2003 Jun 18 [cited 2022 May 15];41(12):2114–8. Available from: https://pubmed.ncbi.nlm.nih.gov/12821233/eng
dcterms.referencesMarenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, et al. N -Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty. New England Journal of Medicine. 2006 Jun 29;354(26):2773–82.eng
dcterms.referencesSudarsky D, Naami R, Shehadeh F, Elias A, Kerner A, Aronson D. Risk of Worsening Renal Function Following Repeated Exposures to Contrast Media During Percutaneous Coronary Interventions. JAHA 2021;10:e021473. https://doi.org/10.1161/JAHA.121.021473.eng
oaire.versioninfo:eu-repo/semantics/acceptedVersion
sb.programaEspecialización en Medicina Internaspa
sb.sedeSede Barranquillaspa

Archivos

Bloque original
Mostrando 1 - 2 de 2
Miniatura
Nombre:
PDF_Resumen.pdf
Tamaño:
175.08 KB
Formato:
Adobe Portable Document Format
Descargar
No hay miniatura disponible
Nombre:
PDF.pdf
Tamaño:
1.36 MB
Formato:
Adobe Portable Document Format
Descargar

Colecciones

Especialización

Universidad Simón Bolívar: Todos los derechos reservados / Sistema de biblioteca